BUSINESS● LOW2h ago · Sep 3, 2026, 10:30 PM
Federal Circuit Affirms Judgment that Swiss Pharma Company Did Not Infringe Iron Deficiency Therapy Patent Claims
ipwatchdog.com · United States · global
A Federal Circuit court has affirmed a judgment that a Swiss pharmaceutical company did not infringe patent claims for an iron deficiency therapy. This ruling clarifies intellectual property rights within the pharmaceutical industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS23m agoVolkswagen to cut another 50,000 jobs to counter tariffs and Chinese competitionFrance 24 [en]BUSINESS36m agoDocusign signals FY2027 ARR growth of 8.5%-9.0% as IAM targets 18%-19% of total ARR exiting Q4Seeking Alpha TechBUSINESS42m agoConstruction starts on North Coast Transmission Line between Prince George and northwest B . C . cbc.ca · CanadaBUSINESS42m agoFox News Parts Ways With Anchor Maria Bartiromo After 12 Years1150wima.iheart.com · United States